Zoli Mikoczy Selected Research

Mutagens

1/2004

Epidemiological evaluation of cytogenetic biomarkers as potential surrogate end-points for cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zoli Mikoczy Research Topics

Disease

2	Neoplasms (Cancer) 01/2011 - 01/2004
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Eczema 03/2007
1	Hypopituitarism (Sheehan's Syndrome) 04/2004
1	Pituitary Neoplasms (Pituitary Adenoma) 04/2004
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2004

Drug/Important Bio-Agent (IBA)

2	insulin receptor-related receptor (IRR)IBA 01/2011 - 03/2007
1	Ethylene Oxide (Oxirane)IBA 01/2011
1	Biomarkers (Surrogate Marker)IBA 01/2004
1	MutagensIBA 01/2004

Therapy/Procedure

1	Radiotherapy 04/2004